Centice to Launch New Drug Verification System at NACDS
PASS Rx empowers pharmacists to increase efficiency, optimize workflow and provides
improved quality of dispensed medications
Morrisville, N.C. - August 20, 2008 - Centice Corporation, a leader in drug verification, today announced plans to unveil its PASS Rx™ product at the upcoming National Association of Chain Drug Stores show in San Diego, August 23rd to the 26th. This is the first time a solution has been offered that verifies the majority of oral solid pharmaceuticals dispensed in retail pharmacies. Product demonstrations will be available at booth #2318.
According to a 2003 study by Auburn University, an estimated 52 million errors occur each year during the filing of 3.5 billion prescriptions in the U.S.
"There is growing pressure on pharmacists to do more without sacrificing quality," said Ray W. Swanson, President and CEO of Centice. "Our goal is to help pharmacists improve quality, streamline workflow and become more efficient at delivering enhanced patient care."
PASS Rx employs patented sensor technologies to generate a unique spectral fingerprint and image data of the size, color and shape of the drug. This information is compared to Centice’s proprietary database for an objective and reliable verification, thus improving the accuracy of the dispensed pharmaceutical. Additionally,
• PASS Rx verifies the drug and strength of the dispensed pharmaceutical through the capped vial in an average of 6 seconds, which fits seamlessly into the pharmacy’s workflow.
• PASS Rx also offers a compact and easy-to-use system that enhances both the fulfillment and final verification processes, thus improving both quality and productivity in pharmacy operations.
The initial roll out of PASS Rx is targeted to select pharmacies while Centice scales up its manufacturing.
Pharmacists looking to learn more about PASS Rx, please visit www.centice.com.